Circulating Tumour DNA as a Biomarker Source in Metastatic Prostate Cancer

Circulating Tumour DNA as a Biomarker Source in Metastatic Prostate Cancer

Tumour molecular features are increasingly linked to treatment response and patient prognosis in advanced prostate cancer. Plasma cell-free circulating tumour DNA (ctDNA) isolated from a minimally invasive blood draw offers a convenient source of tumour material to develop clinical biomarkers. Impor...

Full description

Bibliographic Details
Main Author: Gillian Vandekerkhove, Alexander Wyatt
Format: Article
Language:English
Published: The Société Internationale d’Urologie (SIU) 2020-10-01
Series:Société Internationale d’Urologie Journal
Subjects:
circulating tumour dna
cell-free nucleic acids
prostatic neoplasms
castration-resistant
liquid biopsy
recombinational dna repair
dna mismatch repair
androgen antagonists
biomarkers
Online Access:https://siuj.org/index.php/siuj/article/view/36/10

Internet

https://siuj.org/index.php/siuj/article/view/36/10

Similar Items